Author Archives: BlueberryDev

Beaumont RCSI Cancer Centre COVID-19 Restrictions

All elective services for patients that need to attend the hospital for scheduled appointments and procedures are running as normal with some exceptions.

Clinic appointments have been reconfigured to facilitate physical & social distancing. Where appropriate, we are offering telephone and video virtual out-patient consultations to patients, especially for patients with long term conditions who require ongoing management and may not need to attend for their consultation in person.

It is very important that you do not attend for your appointment if you have a temperature or are feeling unwell. Please phone the number on you appointment letter to reschedule

We would like to reassure you that your health and safety is our first priority.   We will continue to adapt and change our service to meet the needs of our patients in accordance with national guidance.

This link outlines what you should expect if you have to come to Beaumont Hospital –

Visiting remains very limited and the hosptial understands  that visiting for patients is important so keep in touch by mobile or FaceTime. Beaumont continues to facilitate care / comfort packages from families and loved ones. See HERE for more details

Enhanced visiting commenced on Monday 19th July

From Monday 19th July enhanced visiting recommence in Beaumont Hospital.  Local guidelines will apply to protect patients and staff. Please contact the ward directly to discuss.

Compliance with hand hygiene, facemask wearing & cough/sneeze etiquette remains mandatory.

Please do not attend the Hospital without a visiting appointment. Persons that attend without an appointment will not be permitted.

Thank you for your cooperation.

Radiotherapy Treatment and Appointments at St Luke’s Radiation Oncology Network

For information about COVID 19 if you are attending Radiotherapy Services Click Here

RCSI and Cancer Trials Ireland form partnership to advance cancer clinical trials

Cancer trials test new and more effective ways to prevent, diagnose, and treat cancer. Trials can involve testing new drugs or combinations of commonly used drugs, new therapies, new ways of treating cancer, or new ways of diagnosing cancer.They may test new radiotherapy schedules, surgical techniques, medical devices, or physical therapies. They can also involve investigating blood samples and tissues.

RCSI and Cancer Trials Ireland have formed a partnership to respond to the Health Research Board’s Cancer trials in Ireland 2021 funding call. This programme seeks to support the establishment of cancer trial delivery  Clusters and a National Cancer Clinical Trials Network with the aim of enabling the development and  delivery of a high-quality portfolio of cancer clinical trials with relevance to health and care needs in Ireland.

The overall goal of the new HRB’s cancer trials funding model  is to support an appropriate infrastructure; enabling Irish patients to access a diverse portfolio of high-quality, safe  and compliant cancer clinical trials in Ireland.

The scheme will provide support for an appropriate entity with a previous track record of providing clinical trial services and supports to act as the national Cancer Clinical Trials Network, to provide  sponsorship oversight, support services and networking activities to the approved Clusters. National Cancer Clinical Trials Network applicants were expected to partner with an academic host institution.

Cancer Trials Ireland has been striving since 1996 to reach the highest level in the international cancer clinical research world, in 2016 the Group is now recognised as an important partner by many of the leading cancer treatment development agencies in the world, both from the academic and pharmaceutical sector. Today it counts more than 95% of Ireland’s cancer treating consultants among its membership working together to develop some of the most exciting new treatments in some of the most challenging and complex areas of clinical research. We pride ourselves on the fact that our work is bringing these new research based treatment options to cancer patients in Ireland with 6727 patients on trial in 2015. With continued support and perseverance this figure is increasing all the time.

Cancer Clinical Trials Unit Educational Bursary

This award is designed to support the professional development of Non Consultant Hospital Doctors (NCHDs) whoare committed to training in Medical Oncology and Haematology and is open to Specialist Registrars, Registrars,SHOs and Interns. The bursary will be awarded to the successful applicant who has identified and committed to a 3rdlevel post graduate course relating to cancer or to attend an educational meeting with a view to presenting research.

More information available here